Condition

Gastric Cancer Adenocarcinoma Metastatic clinical trials and research

• 7Clinical trials
• 7Countries

Newest Gastric Cancer Adenocarcinoma Metastatic clinical trials

All recruiting trials (7)

• Fruquintinib plus nab‑paclitaxel with iparomlimab and tuvonralimab for people with advanced gastric or GEJ cancer after immunotherapy

  This trial tests whether adding fruquintinib and two immune drugs (iparomlimab and tuvonralimab) to nab‑paclitaxel helps people with advanced gastric cancer whose disease progressed after first‑line immunotherapy.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07392346

• Lenvatinib with nivolumab and chemotherapy for metastatic gastric cancer with malignant ascites

  This trial tests whether adding lenvatinib to nivolumab plus chemotherapy helps people with metastatic gastric or gastroesophageal junction adenocarcinoma who have peritoneal metastases and significant malignant ascites.

  Recruiting Phase 1/2 Asan Medical Center · Seoul · NCT07149090

• Zolbetuximab with paclitaxel and ramucirumab for CLDN18.2-positive stomach and gastro‑esophageal junction cancer

  This treatment tests whether adding zolbetuximab to paclitaxel and ramucirumab helps adults with metastatic gastro‑esophageal adenocarcinoma whose tumors are CLDN18.2‑positive live longer.

  Recruiting Phase 2 Universitaire Ziekenhuizen KU Leuven · Antwerp and 5 other locations · NCT06962137

• Testing BDC-4182 for advanced gastric and gastroesophageal cancer

  This study is testing a new drug called BDC-4182 to see if it's safe and how well it works for people with advanced gastric and gastroesophageal cancer.

  Recruiting at 16 sites Phase 1/2 Bolt Biotherapeutics, Inc. · Darlinghurst, New South Wales and 15 other locations · NCT06921837

• Investigating OKN4395 and Pembrolizumab for Solid Tumors

  This study is testing a new drug called OKN4395, alone and with another drug called pembrolizumab, to see if it can help people with solid tumors who have run out of other treatment options.

  Recruiting at 10 sites Phase 1 Epkin · Beverly Hills, California and 9 other locations · NCT06789172

• New treatment for advanced gastric cancer using TAS-102, bevacizumab, and camrelizumab

  This study is testing a new combination of medications for people with advanced stomach cancer who haven't had success with other treatments to see if it can help them.

  Recruiting Phase 2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing, Beijing Municipality · NCT06711471

• Examining the relationship between Sintilimab levels and treatment outcomes in advanced gastric cancer patients

  This study is testing how the levels of Sintilimab in the blood affect treatment results and side effects for people with advanced gastric cancer.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu · NCT06702683

Related topics

Quick answers

How many Gastric Cancer Adenocarcinoma Metastatic clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in China (3 trials), Australia (2 trials), South Korea (2 trials), Taiwan (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →